Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 27, 2025 15:28 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Contracts with LabCorp to Support DNA/GPS Platform for Advanced Genetic and Retinal Health Screening

Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and Echocardiograms
June 13, 2025 05:15 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives

APOLLO BEACH, Fla., June 13, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneer in advanced retinal imaging and precision medicine, is...
May 06, 2025 20:00 ET | Source: Optigo Biotherapeutics Inc.

Optigo Biotherapeutics Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at the ARVO 2025 Conference

Optigo Bio Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at ARVO 2025
May 05, 2025 06:15 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs

APOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today a new laboratory lease agreement with life...
February 20, 2025 06:30 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring

RETINALGENIX TECHNOLOGIES BREAKTHROUGH IN REAL-TIME 24/7 REMOTE OCULAR MONITORING High-Resolution Retinal Imaging Using Both Near Infrared And Green Modes
December 26, 2023 12:45 ET | Source: RetinalGeniX Technologies, Inc.

RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration

RETINALGENIX AND MEDSAN CONTRACT TO ADVANCE STUDY INTENDED TO PERSONALIZE MEDICAL EVALUATIONS FOR PATIENTS RECEIVING TREATMENT FOR WET MACULAR DEGENERATION
June 06, 2019 12:30 ET | Source: Reports And Data

Diabetic Retinopathy Market to Reach USD 13.04 billion By 2026 | Reports And Data

Factors contributing to high CAGR are growing prevalence of diabetes along with rising incidence of blindness. Moreover, increase in purchasing power and the dread of losing vision have augmented the...